secwatch.observer — SEC 8-K summary
======================================

Issuer:     Unicycive Therapeutics, Inc. (UNCY)
CIK:        0001766140
Form:       8-K
Filed at:   2024-02-21T23:59:59+00:00
Accession:  0001213900-24-015753
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Unicycive regains compliance with Nasdaq minimum market value and bid price rules
--------------------------------------------------------------------------------

- On Feb 21, 2024, Nasdaq notified Unicycive that it regained compliance with the $35M minimum market value and $1.00 minimum bid price requirements.
- Non-compliance notices were originally received on Sept 19, 2023, for both Nasdaq Listing Rules 5550(b)(2) and 5550(a)(2).
- The compliance matters are now closed with no further action required.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1766140/000121390024015753/0001213900-24-015753-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1766140/000121390024015753/ea0200428-8k_unicyc.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-015753

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer